Drug Profile
Research programme: G protein-coupled receptor modulators - Ortho-McNeil-Janssen Pharmaceuticals
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ortho-McNeil-Janssen Pharmaceuticals
- Developer Johnson & Johnson Innovative Medicine
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in USA
- 07 Jan 2011 Early research in Undefined indication in USA (unspecified route)